Sylvie Berger

Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme

François Mailliet, Gilles Ferry, F Vella et al. · Biochemical Pharmacology · 2005 · 123 citations

Aldo-keto Reductase, Biochemistry, Medicine +7

Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome.

Frédéric De Ceuninck, Estelle Marcheteau, Sylvie Berger et al. · PubMed · 2005 · 53 citations

Sclerostin, Immunology, Pathology +19

Old and new inhibitors of quinone reductase 2

Gilles Ferry, Sabrina Hecht, Sylvie Berger et al. · Chemico-Biological Interactions · 2010 · 52 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Aldo-keto Reductase +8

Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice

Klaus Seedorf, Csaba Weber, Cédric Vinson et al. · JHEP Reports · 2022 · 44 citations · Full text

MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co‐substrate

Jean A. Boutin, Estelle Marcheteau, Philippe Hennig et al. · Journal of Pineal Research · 2008 · 38 citations